Shanghai Fosun Pharmaceutical Subsidiary Drug Registration Application Accepted
I'm PortAI, I can summarize articles.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that a drug registration application from one of its subsidiaries has been accepted by the relevant regulatory authority. This announcement complies with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. No specific details about the drug or subsidiary were disclosed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments